Thieler Law Corp, member of the Investor Attorney Network, is investigating whether certain officers and directors of Qiagen N.V. (NYSE: QGEN) violated securities laws in connection with certain financial statements.

The investigation seeks to discover if possible claims on behalf of purchasers of the securities of Qiagen N.V. (NYSE: QGEN) concerning whether a series of statements by QIAGEN N.V. regarding its business, its prospects and its operations were materially false and misleading at the time they were made.

On October 7, 2019, the Company revealed that third quarter results would come in below previous estimates. Furthermore, the Company announced its long-term CEO, Peer M. Schatz, would resign as CEO and Chairman of the Board effective immediately.

Following this news, NYSE: QGEN fell over 20% on October 8, 2019, from $32.06 per share to $25.41 per share.

Based in Venlo, the Netherlands, and founded in 1986 Qiagen N.V. provides sample to insight solutions that transform biological materials into molecular insights worldwide.

If you purchased shares of QIAGEN N.V. (NYSE: QGEN) on or before October 7, 2019, you should contact Thieler Law Corp at mail@thielerlaw.com or call +1 (619) 377 - 4324.

Thieler Law Corp purchases advertisements on search engines, social media sites and other websites. If you send us information, note that does not create an attorney-client relationship with the firm. Materials are provided for informational purposes only and do not constitute legal advice. We are only licensed to practice law in Germany. We are neither licensed nor qualified to render advice on US Federal or State law.

Thieler Law Corp

2534 State Street - Suite 406,

San Diego, CA 92101

by

email: mail@thielerlaw.com 

or

telephone at +1 (619) 377 - 4324

or

visit our website http://www.thielerlaw.com/ 

or

Facsimile: +1 (619) 785 – 3185